Based on announcements in early 2026, the FDA and HHS signaled reclassifying a group of peptides, including BPC-157, TB-500, and injectable GHK-Cu, toward Category 1, which makes them eligible for use by licensed compounding pharmacies preparing individualized medications under a prescription
Development and initial validation of a measure of drinking urges in abstinent alcoholics
Which pharmacy fills my prescription
Progress reviews were practical, not generic copy-paste advice
In the SURPASS-2 study, Mounjaro 15 mg reduced A1C by 2.3% compared to 1.86% with semaglutide (1 mg) over 40 weeks
Does fatigue from GLP-1 medications go away on its own